Season 2
In the most recent episode of “There’s More to IT,” host Jason Claybrook discussed the widespread exposure of Per and Polyfluoroalkyl Substances, better known as PFAS, in various aspects of everyday life. His guest was Yuran Li, the director of MS Commercial Strategies at Alternative Biomedical Solutions — a Texas based laboratory. The two talked…
Latest
Season 2
Mastering the Science Behind Creating an IT Department
In this episode of There’s More to IT, host, Jason Claybrook, sat down with David McLaughlin, President & CEO, Columbia Advisory Group. The two discuss McLaughlin’s journey in the field, the importance of the advisory component in CAG’s work, and CAG’s role in higher education. McLaughlin co-founded Columbia Advisory Group a little over 10…
Food & Beverage
Is Holistic Nutrition the Answer for Improving Overall Nutritional Needs?
In the latest episode of the podcast “There’s More to IT,” host Jason Claybrook brings on his wife Niki, and diverges from technology to discuss maintaining healthy-eating habits, as more and more people return to work traveling as pandemic restrictions ease. As a holistic nutrition consultant based in Texas, Claybrook consults clients that have…
Season 2
Technology Leaders Are No Longer Behind the Scenes, They Are Integral for Driving Strategy
Toby Buckalew, Interim CIO, Columbia Advisory Group, is a leading technology strategist with over thirty years of industry experience. Jason Claybrook sat down with Buckalew for an in-depth discussion on his career and insights into the current state of IT management. Buckalew witnessed plenty of technology evolution and innovation during his lengthy career in…
Sciences
The Industry That is Depending on Science and Regulation to Grow
Yuran Li, Director, MS Commercial Strategies, Alternative Biomedical Solutions (ABS), is a biochemist by training. Still, his fascinations with physics, math, and probability have led him down some interesting paths, including some stints in the professional poker world. Lucky for ABS, he chose the science route. Cannabis is a schedule 1 drug classification by the…
Latest
From Heritage to Hospitality: The Faherty Blueprint for Authentic, Community-Centered Branding
Great clothes may be where it starts, but today’s shoppers are looking for something more — a sense of connection, belonging, and shared purpose. Research shows that 90% of consumers value authenticity when deciding which brands to support: a clear reminder that while quality and design remain vital, meaning has become the new measure of loyalty….
The Gut Reset Revolution: How Food-as-Medicine Became the New Foundation for Wellness
Gut health has moved from fringe to front page, with consumers overwhelmed by protocols, powders, and “miracle” cleanses. As interest surges, so do questions about what actually works day to day—and why it matters now. One reason: an estimated 65% of the population is dairy intolerant, complicating popular bovine colostrum trends cited for immunity…
Driving Real Change: How ZM Trucks Is Building the Future of Zero-Emission Trucking
As the U.S. accelerates its push toward cleaner freight transport, policy and market forces are reshaping what’s possible in trucking. The EPA’s Phase 3 greenhouse gas emissions standards for heavy-duty vehicles, finalized on March 29, 2024, establish stricter CO₂ limits for model years 2027 through 2032. The rule is technology-neutral and performance-based, allowing manufacturers…
The Open Road to Reform: Why Healthcare Needs Disruption, Innovation, and the Return of Real Competition
The U.S. healthcare system is at a crossroads — facing rising costs, limited competition, and a widening gap between innovation and accessibility. According to projections from the Centers for Medicare & Medicaid Services (CMS), national health spending is expected to grow faster than the overall economy over the next decade — about 5.8% per year…